Lucid Diagnostics completes $70 million initial public offering
Company's esophageal cancer prevention tests developed jointly by medical school faculty at Case Western Reserve University and University Hospitals Lucid Diagnostics Inc., a compa…
Company's esophageal cancer prevention tests developed jointly by medical school faculty at Case Western Reserve University and University Hospitals Lucid Diagnostics Inc., a compa…